FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We have now added a new section called the "Assay History List" to the "At A Gla...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...